Updated:
Siromed
Siromed is a Waltham-based single-family office investing in healthcare, biotech, private equity, and real estate.
Siromed
Siromed operates as a single-family office headquartered in Waltham, Massachusetts. The firm was established by a family whose wealth derived from the healthcare and life sciences industries, though the specific founding year and founding individual are not publicly documented. Siromed does not maintain a public website or social media presence, consistent with a preference for privacy. The firm allocates capital across a diversified portfolio that includes private equity, real estate, venture capital, and public equities. It focuses primarily on healthcare services, biotechnology, and medical devices, reflecting the family's industry expertise. Siromed has been known to make direct investments in early- and growth-stage healthcare companies, as well as co-invest alongside institutional private equity firms. Real estate holdings include commercial properties in the Greater Boston area. Siromed does not disclose its total assets under management or the size of its professional staff. The office operates with a lean team, typical of single-family offices of comparable scale. No additional offices beyond Waltham have been identified, and the firm does not report to public databases. The firm maintains a low public profile, with no recent operational events reported in media. A structural differentiator for Siromed is its ability to hold assets for extended periods, without the liquidity pressures faced by institutional fund managers. This patient-capital approach allows it to invest in illiquid healthcare ventures and real estate across market cycles. The firm's succession and governance structure remain private, a common trait among family offices that prioritize discretion over external transparency.
General information
Firm type
Single Family Office
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Waltham
Corporate office
Waltham, MA, United States
Sector focus
Frequently asked questions
Who runs investment decisions at Siromed?
Siromed does not publicly name its investment principals or leadership team. The firm operates privately and does not disclose the individuals responsible for investment decisions.
Is Siromed structured as a single-family office or does it operate like a venture firm?
Siromed operates as a single-family office that manages wealth generated from healthcare and life sciences. It does not operate as a multi-family office or venture capital firm open to outside investors.
What investment stages does Siromed typically target?
Siromed is known to invest across early-stage venture and growth-stage private equity, with a focus on healthcare and biotech companies. It also holds real estate assets and liquid public securities, indicating a multi-stage, multi-asset approach.
Does Siromed participate in fund commitments or only direct deals?
Siromed appears to invest both directly into companies and through co-investments alongside institutional private equity firms. The firm is not known to commit capital to commingled funds as a limited partner.
Which sectors does Siromed explicitly avoid?
Siromed has not publicly stated any excluded sectors. Based on disclosed activity, the firm focuses on healthcare, biotech, medtech, and real estate, and does not appear active in technology, fintech, or energy.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: